Close Menu

NEI

A team led by National Eye Institute researchers picked out B3GLCT and BLOC1S1 as the most plausible target genes in an age-related macular degeneration analysis.

The institutes will lead a consortium of researchers investigating the molecular underpinnings of diabetic retinopathy, a key cause of blindness.

In Nature this week: 3D genome structures, CRISPR approach prevents retinitis pigmentosa in mice, and more.

Researchers describe a rare genetic disorder that leads to deafness, blindness, and albinism, that's more likely among children of deaf parents, the Washington Post reports.

Researchers find that a woman's genetic risk for age-related macular degeneration is influenced by lifestyle factors.

NEW YORK (GenomeWeb) – Cellular Dynamics International today announced a $1.2 million contract from the National Eye Institute to manufacture stem cells for use in the development of a new potential treatment for dry age-related macular degeneration.

NEW YORK (GenomeWeb News) – A trio of studies published online yesterday in Nature Genetics are revealing new, rare risk loci for age-related macular degeneration.

The institute will fund between four and six projects annually that aim to integrate data analyses of research that has been carried out on vision disorders.

A new program will fund training in genomics and informatics for genotype-phenotype studies of eye diseases.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.